OOIR: Observatory of International Research

Papers

(The median citation count of Molecular Carcinogenesis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Immunogenic cell death in colon cancer prevention and therapy	61
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses	55
MiR‐15a‐3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer	39
Fibroblast growth factor‐2, derived from cancer‐associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling	38
Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple‐negative breast cancer	36
Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy	36
Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells	35
Polyomavirus‐driven Merkel cell carcinoma: Prospects for therapeutic vaccine development	32
PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma	31
The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy	31
Inhibition of Cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagy	31
Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR‐942‐5p and releasing DLG2 via Hippo‐YAP signaling	29
Breast cancer stem cells: A review of their characteristics and the agents that affect them	28
Redox regulation by SOD2 modulates colorectal cancer tumorigenesis through AMPK‐mediated energy metabolism	27
M2‐like tumor‐associated macrophages‐secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β‐catenin pathway in thyroid cancer	27
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells	27
Nicotinamide N‐methyltransferase decreases 5‐fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect	25
Tocilizumab inhibits IL‐8 and the proangiogenic potential of triple negative breast cancer cells	25
Alternative splicing related genetic variants contribute to bladder cancer risk	25
EGFR‐ERK pathway regulates CSN6 to contribute to PD‐L1 expression in glioblastoma	25
Transcriptome profiling reveals that VNPP433‐3β, the lead next‐generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial–mesenchymal transition and stem cell marker	24
Saccharide analog, 2‐deoxy‐d‐glucose enhances 4‐1BB‐mediated antitumor immunity via PD‐L1 deglycosylation	24
IL‐6 and IL‐8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor	23
T‐cell receptor affinity in the age of cancer immunotherapy	23
lncRNA CERS6‐AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR‐125a‐5p to upregulate BAP1 expression	22

CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple‐negative breast cancer	22
Inhibiting Wnt/beta‐catenin in CTNNB1‐mutated endometrial cancer	22
USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51‐AKT1 signaling	22
Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway	21
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response	20
The LncRNA FGD5‐AS1/miR‐497‐5p axis regulates septin 2 (SEPT2) to accelerate cancer progression and increase cisplatin‐resistance in laryngeal squamous cell carcinoma	19
Identification and characterization of novel SCR7‐based small‐molecule inhibitor of DNA end‐joining, SCR130 and its relevance in cancer therapeutics	19
ALKBH5‐mediated m6A‐demethylation of USP1 regulated T‐cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B	19
CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells	19
Focal adhesion kinase (FAK) inhibitor‐defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream mo	19
L‐fucose, a sugary regulator of antitumor immunity and immunotherapies	18
Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer	18
N⁶‐Methyladenosine (m⁶A) readers are dysregulated in renal cell carcinoma	18
MicroRNA‐141‐3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous sclerosis complex 1	17
The humanized mouse: Emerging translational potential	17
miR‐885‐5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma	17
Autophagy modulates FSS‐induced epithelial–mesenchymal transition in hepatocellular carcinoma cells	16
USF1‐induced overexpression of long noncoding RNA WDFY3‐AS2 promotes lung adenocarcinoma progression via targeting miR‐491‐5p/ZNF703 axis	16
SALL4 promotes tumor progression in breast cancer by targeting EMT	16
Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer	16
A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR‐30d‐5p/HDAC9 axis and the epithelial–mesenchymal transition	15
Eugenol modulates genomic methylation and inactivates breast cancer‐associated fibroblasts through E2F1‐dependent downregulation of DNMT1/DNMT3A	15
LINC02381 aggravates breast cancer through the miR‐1271‐5p/FN1 axis to activate PI3K/AKT pathway	15
Role of class I histone deacetylases in the regulation of maspin expression in prostate cancer	14
The role of transforming growth factor‐beta in immune suppression and chronic inflammation of squamous cell carcinomas	14
RNA‐seq reveals novel cancer‐selective and disease subtype‐independent mechanistic targets of withaferin A in human breast cancer cells	14
FAM129B‐dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells	14
Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo	14
Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non–small cell lung cancer cells via endoplasmic reticulum stress‐mediated degradation of Mcl‐1	14
Anticancer activities of parthenolide in primary effusion lymphoma preclinical models	14
Hyperactivation of MEK/ERK pathway by Ca²⁺/calmodulin‐dependent protein kinase kinase 2 promotes cellular proliferation by activating cyclin‐dependent kinases and minichromosome maintenance	14
LncRNA UCA1 maintains the low‐tumorigenic and nonmetastatic status by stabilizing E‐cadherin in primary prostate cancer cells	13
FAP^high α‐SMA^low cancer‐associated fibroblast‐derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downs	13
HPV‐16/18 E6‐induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1	13
Slow N‐acetylation as a possible contributor to bladder carcinogenesis	13
CAF‐derived exosomes transmitted Gremlin‐1 promotes cancer progression and decreases the sensitivity of hepatoma cells to sorafenib	13
VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype	13
TP53 mutations in head and neck cancer	13
Computational modeling of malignant ascites reveals CCL5–SDC4 interaction in the immune microenvironment of ovarian cancer	13
A rohitukine derivative IIIM‐290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells	13
miR‐506‐loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple‐negative breast cancer aggressiveness	12
CMTM4 regulates epithelial–mesenchymal transition and PD‐L1 expression in head and neck squamous cell carcinoma	12
Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma	11
Targeting mitochondrial metabolism for metastatic cancer therapy	11
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres	11
Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer	11
USP39 mediates p21‐dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis	11
Genetic variants of the peroxisome proliferator‐activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer	11
Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1‐mediated EMT	11
Dihydromethysticin, a natural molecule from Kava, suppresses the growth of colorectal cancer via the NLRC3/PI3K pathway	11

In vivo CRISPR–Cas9 knockout screening using quantitative PCR identifies thymosin beta‐4 X‐linked that promotes diffuse‐type gastric cancer metastasis	11
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity	11
Myeloid derived suppressor cells in cancer, premalignancy and inflammation: A roadmap to cancer immunoprevention	10
Tumor‐derived exosomes: Key players in non‐small cell lung cancer metastasis and their implication for targeted therapy	10
YAP/TEAD4‐induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma	10
PCAT6 mediates cellular biological functions in gastrointestinal stromal tumor via upregulation of PRDX5 and activation of Wnt pathway	10
Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell composition	10
Development and validation of 3‐CpG methylation prognostic signature based on different survival indicators for colorectal cancer	10
Amateur antigen‐presenting cells in the tumor microenvironment	10
Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B‐related hepatocellular carcinoma	10
TNF‐α‐dependent lung inflammation upregulates superoxide dismutase‐2 to promote tumor cell proliferation in lung adenocarcinoma	9
Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells	9
lnc‐HOTAIR predicts hepatocellular carcinoma in chronic hepatitis C genotype 4 following direct‐acting antivirals therapy	9
The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme	9
Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma‐specific survival	9
A novel terpenoid class for prevention and treatment of KRAS‐driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems	9
Pharmacologic inhibition of ataxia telangiectasia and Rad3‐related (ATR) in the treatment of head and neck squamous cell carcinoma	9
Methylseleninic acid overcomes programmed death‐ligand 1‐mediated resistance of prostate cancer and lung cancer	9
Twist1 is required for the development of UVB‐induced squamous cell carcinoma	9
Associations of genetically predicted circulating insulin‐like growth factor‐1 and insulin‐like growth factor binding protein‐3 with bladder cancer risk	9
H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4	9
SCR7, an inhibitor of NHEJ can sensitize tumor cells to ionization radiation	9
CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas	8
DDIT4 promotes malignancy of head and neck squamous cell carcinoma	8
Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration‐resistant prostate cancer	8
Long noncoding RNA RP11‐626G11.3 promotes the progression of glioma through miR‐375‐SP1 axis	8
LINC00662 modulates cervical cancer cell proliferation, invasion, and apoptosis via sponging miR‐103a‐3p and upregulating PDK4	8
Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR)	8
ARNT‐dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer	8
Immunomodulatory role of thrombin in cancer progression	8
Circ‐E‐Cad encodes a protein that promotes the proliferation and migration of gastric cancer via the TGF‐β/Smad/C‐E‐Cad/PI3K/AKT pathway	8
Enrichment of progenitor cells by 2‐acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo	8
Integrating the immune microenvironment of prostate cancer induced bone disease	8
HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells	8
Quercetin attenuates the proliferation of arsenic‐related lung cancer cells via a caspase‐dependent DNA damage signaling	8
Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer	8
SIRT2 modulates VEGFD‐associated lymphangiogenesis by deacetylating EPAS1 in human head and neck cancer	8
Suppression of beta 2 adrenergic receptor actions prevent UVB mediated cutaneous squamous cell tumorigenesis through inhibition of VEGF‐A induced angiogenesis	8
Common tumor‐suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells	8
Central memory phenotype drives success of checkpoint inhibition in combination with CAR T cells	8
SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain‐dependent regulation of Wnt/β‐catenin signaling	8
Toll‐like receptor‐4 deficiency inhibits ultraviolet radiation‐induced tumor development by modulation of immune and inflammatory responses	8
Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells	7
Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression	7
Downregulation of STK25 promotes autophagy via the Janus kinase 2/signal transducer and activator of transcription 3 pathway in colorectal cancer	7
Histone demethylase JMJD1A in cancer progression and therapeutic resistance	7
Diagnostic potential of circulating cell‐free nuclear and mitochondrial DNA for several cancer types and nonmalignant diseases: A study on suspected cancer patients	7
Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney rena	7
Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA‐30a in breast cancer	7
Identification of a novel TNRC18‐RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML‐RARA	7
Mefloquine induces ER stress and apoptosis in BRAFi‐resistant A375‐BRAF^V600E/NRAS^Q61K malignant melanoma cells targeting intracranial tumors in a bioluminescent murine model	7
DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice	7
Alternative splicing: An important regulatory mechanism in colorectal carcinoma	7
Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1	7
Pharmacologic approaches to amino acid depletion for cancer therapy	7
A review of Plks: Thinking outside the (polo) box	7
MYC‐binding lncRNA EPIC1 promotes AKT‐mTORC1 signaling and rapamycin resistance in breast and ovarian cancer	7
Cucurbitacin I (JSI‐124)‐dependent inhibition of STAT3 permanently suppresses the pro‐carcinogenic effects of active breast cancer‐associated fibroblasts	7
XB130, regulated by miR‐203, miR‐219, and miR‐4782‐3p, mediates the proliferation and metastasis of non‐small‐cell lung cancer cells	7
HIF‐1α‐regulated stanniocalcin‐1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway	7
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma	7
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway	6
Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma	6
Low expression of lncRNA SBF2‐AS1 regulates the miR‐302b‐3p/TGFBR2 axis, promoting metastasis in laryngeal cancer	6
Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma	6
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism	6
The potential underlying mechanism of the leukemia caused by MLL‐fusion and potential treatments	6
MicroRNA‐519d‐3p antagonizes osteosarcoma resistance against cisplatin by targeting PD‐L1	6
Effects of radiation on tumor vasculature	6
Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma	6
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells	6
Transcriptional repression of E‐cadherin in nickel‐exposed lung epithelial cells mediated by loss of Sp1 binding at the promoter	6
Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma	6
Review: PD‐L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer	5
Role of hemoglobin alpha and hemoglobin beta in non‐small‐cell lung cancer based on bioinformatics analysis	5
p21‐activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1	5
PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia	5
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling	5
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway	5
PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β‐catenin pathway	5

Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells	5
Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation	5
Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors	5
Cancer biology functional genomics: From small RNAs to big dreams	5
Loss of prdm1a accelerates melanoma onset and progression	5
Contaminated and misidentified cell lines commonly use in cancer research	5
The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance	5
Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype	5
RAS induced senescence of skin keratinocytes is mediated through Rho‐associated protein kinase (ROCK)	5
Silencing of UAP1L1 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma	5
Long noncoding RNA TFAP2A‐AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR‐1297 and regulating TFAP2A expression	5
HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z1	5
Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells	5
FOXD3 suppresses epithelial–mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma	4
Germline MC1R variants and frequency of somatic BRAF, NRAS, and TERT mutations in melanoma: Literature review and meta‐analysis	4
CircSPAG16 suppresses cadmium‐induced transformation of human bronchial epithelial cells by decoying PIP5K1α to inactivate Akt	4
KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation	4
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF‐β1/pERK signaling pathway	4
Inhibition of p62/SQSTM1 sensitizes small‐cell lung cancer cells to cisplatin‐induced cytotoxicity by targeting NEDD9 expression	4
Doublecortin‐like kinase 1 is a therapeutic target in squamous cell carcinoma	4
Gender‐based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum‐fermented rice bran diet against inflammation‐associated colon tumorigenesis	4
Novel MLL/KMT2A‐MON2 fusion in a child with therapy‐related acute myeloid leukemia after treatment for acute promyelocytic leukemia	4
Monocarboxylate transporter 1 is a novel target for breast cancer stem like‐cell inhibition by diallyl trisulfide	4
Nutlin‐3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation	4
Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer	4
m7G‐related genes—NCBP2 and EIF4E3 determine immune contexture in head and neck squamous cell carcinoma by regulating CCL4/CCL5 expression	4
New genetic variations discovered in KRAS wild‐type cetuximab resistant chinese colorectal cancer patients	4
KLF14/miR‐1283/TFAP2C axis inhibits HER2‐positive breast cancer progression via declining tumor cell proliferation	4
Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells	4
IL‐1RN gene polymorphisms reduces thyroid cancer risk in Chinese Han population	4
Low‐dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo	4
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases	4
Periostin secreted from podoplanin‐positive cancer‐associated fibroblasts promotes metastasis of gastric cancer by regulating cancer stem cells via AKT and YAP signaling pathway	4
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder	4
Rapalogs induce non‐apoptotic, autophagy‐dependent cell death in HPV‐negative TP53 mutant head and neck squamous cell carcinoma	4
Deletion of arylamine N‐acetyltransferase 1 in MDA‐MB‐231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis	4
The FoxQ1 transcription factor is a novel regulator of electron transport chain complex I subunits in human breast cancer cells	4
Harnessing the power of the immune system in cancer immunotherapy and cancer prevention	4
NUAK family kinase 2 is a novel therapeutic target for prostate cancer	4
Crucial role of glucosylceramide synthase in the regulation of stem cell‐like cancer cells in B16F10 murine melanoma	3
Proanthocyanidins mitigate bile acid‐induced changes in GSTT2 levels in a panel of racially diverse patient‐derived primary esophageal cell cultures	3
Association of genetic variants of FBXO32 and FOXO6 in the FOXO pathway with breast cancer risk	3
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation	3
Epidermal growth factor receptor signaling in precancerous keratinocytes promotes neighboring head and neck cancer squamous cell carcinoma cancer stem cell‐like properties and phosphoinositide 3‐kinas	3
Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS‐mutant human lung cancer cells	3
CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple‐negative breast cancer by targeting miR‐761/DACT2 signaling axis	3
Stage‐specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis	3
Transcriptional activation of S100A2 expression by HIF‐1α via binding to the hypomethylated hypoxia response elements in HCC cells	3
A potential signaling axis between RON kinase receptor and hypoxia‐inducible factor‐1 alpha in pancreatic cancer	3
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway	3
PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation	3
SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression	3
Metabolic response to radiation therapy in cancer	3
Protective role of histone deacetylase 4 from ultraviolet radiation‐induced DNA lesions	3
Metabolomics‐based classification reveals subtypes of hepatocellular carcinoma	3
Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5	3
Angiopoietin‐like protein 3 promotes colorectal cancer progression and liver metastasis partly via the mitogen‐activated protein kinase 14 pathway	3
Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer	3
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors	3
Role of RNA modifications in carcinogenesis and carcinogen damage response	3
MCPIP1 expression positively correlates with melanoma‐specific survival of patients, and its overexpression affects vital intracellular pathways of human melanoma cells	3
Hypoxic nasopharyngeal carcinoma‐derived exosomal miR‐455 increases vascular permeability by targeting ZO‐1 to promote metastasis	3
Characterization of stage‐specific tumor progression in TMPRSS2‐ERG (fusion)‐driven and non‐fusion‐driven prostate cancer in GEM models	3
Circular RNA ACACA negatively regulated p53‐modulated mevalonate pathway to promote colorectal tumorigenesis via regulating miR‐193a/b‐3p/HDAC3 axis	3
PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming	3
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline‐deficient l‐amino acid‐defined diet prevents hepatocarcinogenesis in mice	3
E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcription	3
Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma	3
Plasma cell‐free DNA methylome profiling in pre‐ and post‐surgery oral cavity squamous cell carcinoma	3
Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer	3
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors	2
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling	2
Targeting SMYD2 inhibits prostate cancer cell growth by regulating c‐Myc signaling	2
Withaferin A inhibits breast cancer‐induced osteoclast differentiation	2
RFC5, regulated by circ_0038985/miR‐3614‐5p, functions as an oncogene in the progression of colorectal cancer	2
Genetic variants in DDO and PEX5L in peroxisome‐related pathways predict non‐small cell lung cancer survival	2
Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer	2
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype	2
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas	2
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies	2
Inhibition of endogenous hydrogen sulfide production suppresses the growth of nasopharyngeal carcinoma cells	2
Comprehensive DNA methylation profiling of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients	2
Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C	2
Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF‐1α/ATG5 axis	2
Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients	2
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype	2
A novel oncogene trigger transposable element derived‐1 promotes oral squamous cell carcinoma progression via evoking immune inhibition	2
ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression	2
ARHGEF40 promotes non‐small cell lung cancer proliferation and invasion via the AKT‐Wnt axis by binding to RhoA	2
Knockdown of UBE2I inhibits tumorigenesis and enhances chemosensitivity of cholangiocarcinoma via modulating p27kip1 nuclear export	2
Insulin‐like growth factor‐2 mRNA‐binding protein 3 promotes cell migration, invasion, and epithelial−mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E‐box‐	2
PARP5B is required for nonhomologous end joining during tumorigenesis in vivo	2
An integrative analysis reveals the prognostic value and potential functions of PSMD11 in hepatocellular carcinoma	2
Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC	2
Colorectal cancer risk susceptibility loci in a Swedish population	2